尿路感染症に対するCefroxadine (CGP-9000) の臨床的検討

DOI Web Site

書誌事項

タイトル別名
  • CLINICAL EVALUATION OF CEFROXADINE (CGP-9000) IN URINARY TRACT INFECTIONS
  • ニョウロ カンセンショウ ニ タイスル Cefroxadine CGP 900

この論文をさがす

抄録

Cefroxadine (CGP-9000, CXD) a new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum was administered orally 250mg 2-3 times a day to 31 patients with urinary tract infections to evaluate therapeutic efficacy. The results obtained as follows:<BR>1) The clinical effects for 24 patients with acute simple cystitis were excellent in 11 cases (45.8%), moderate in 12 cases (50%) and poor in 1 case (4.2%).<BR>2) The clinical effects for 7 patients with chronic complicated urinary tract infections were excellent in 1 case (14.3%), moderate in 3 cases (42.9%) and poor in 3 cases (42.9%).<BR>3) No marked side effects were observed.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ